Gender	Female
E-mail	shoshana.yakar@mssm.edu
Education and Training	Postdoctoral Fellowship, National Institute of Diabetes and Digestive and Kidney Diseases
	Ph.D., Tel-Aviv University

Education and Training	Postdoctoral Fellowship, National Institute of Diabetes and Digestive and Kidney Diseases
	Ph.D., Tel-Aviv University

Dr. Yakar is the co-Director of diabetes research in the Division of Endocrinology, Diabetes and Bone Disease. Her research focuses on the generation, development and use of various murine transgenic and knockout models related to the insulin-like growth factor 1 (IGF-1) signaling system. Dr. Yakar has received numerous awards from the Endocrine Society including The 2001 Molecular and Cellular Research Travel Award.

Shukla V, Coumoul X, Cao L, Wang RH, Xiao C, Xu X, Ando S, Yakar S, Leroith D, Deng C. Absence of the full-length breast cancer-associated gene-1 leads to increased expression of insulin-like growth factor signaling axis members. Cancer Res 2006 July; 66(14): 7151-7157.

Yakar S, Bouxsein ML, Canalis E, Sun H, Glatt V, Gundberg C, Cohen P, Hwang D, Boisclair Y, Leroith D, Rosen CJ. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J Endocrinol 2006 May; 189(2): 289-299.

Pennisi P, Gavrilova O, Setser-Portas J, Jou W, Santopietro S, Clemmons D, Yakar S, Leroith D. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus. Endocrinology 2006 June; 147(6): 2616-2630.

Sadagurski M, Yakar S, Weingarten G, Holzenberger M, Rhodes CJ, Breitkreutz D, Leroith D, Wertheimer E. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol Cell Biol 2006 April; 26(7): 2675-2687.

Samani AA, Yakar S, Leroith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2006 August;.